GPR120 receptor agonists and uses thereof
US8299117B2 · kind B2 · utility
4Cited by
8References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 16, 2010 |
| Grant date | Oct 30, 2012 |
| Priority date | — |
| Expiry date | Feb 7, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
GPR120 agonists are provided. These compounds are useful for the treatment of metabolic diseases, including Type II diabetes and diseases associated with poor glycemic control.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.